Benchmark Reiterates Buy on Surgery Partners, Maintains $47 Price Target

Benchmark analyst Bill Sutherland reiterates Surgery Partners (NASDAQ:SGRY) with a Buy and maintains $47 price target.

Benchmark analyst Bill Sutherland reiterates Surgery Partners (NASDAQ:SGRY) with a Buy and maintains $47 price target.

Total
0
Shares
Related Posts